您的购物车当前为空
别名 KB-004, KB004, Anti-EphA3 MAb
Ifabotuzumab (KB-004)是一种靶向杀伤 EphA3 + 细胞的抗体,可显著降低 CCR10 + 细胞的数量并改善人源化 NSG 小鼠的肺纤维化。
Ifabotuzumab (KB-004)是一种靶向杀伤 EphA3 + 细胞的抗体,可显著降低 CCR10 + 细胞的数量并改善人源化 NSG 小鼠的肺纤维化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,897 | In Stock | |
| 5 mg | ¥ 11,488 | In Stock | |
| 10 mg | ¥ 18,380 | In Stock | |
| 25 mg | ¥ 34,460 | In Stock |
Ifabotuzumab 相关产品
| 产品描述 | Ifabotuzumab (KB-004) is an antibody targeting EphA3+ cells, significantly reducing CCR10+ cells and improving pulmonary fibrosis in humanized NSG mice. |
| 体内活性 | Ifabotuzumab 靶向杀伤 EphA3 + 细胞可显著降低 CCR10 + 细胞的数量并改善人源化 NSG 小鼠的肺纤维化。 |
| 别名 | KB-004, KB004, Anti-EphA3 MAb |
| CAS No. | 2147698-66-4 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容